Dutogliptin Tartrate

度格列汀酒石酸盐

Report date: 2026/02/26 20:00:22
NME

Base Information

Drug NameDutogliptin Tartrate
Drug Alias Name杜拓格利普汀DutogliptineDutogliptina度托格列汀度格列汀 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2ST Elevation Myocardial InfarctionMyocardial Infarction +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[23] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPhenomix
China Registration ClassN/A

Develop Information

Active CompaniesRecardio Inc
Inactive CompaniesForest Laboratories IncPhenomix
Active IndicationsST Elevation Myocardial Infarction
Inactive IndicationsDiabetes Mellitus, Type 2Myocardial InfarctionRenal Insufficiency +[4] 

Other Information

ATC CodeN/A
Related LinksKEGG